The Ritedose Corporation
The Ritedose Corporation (United States) has no DMF, CEP or site registration linked in our records. 8 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “The Ritedose Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/the-ritedose-corporation
Overview
The Ritedose Corporation is a pharmaceutical company headquartered in Columbia, United States.
FDA compliance signals
8 FDA enforcement records linked to this company.
- recall — Class II2026-11-04
Failed Impurities/Degradation Specification
- 4832025-02-28
Investigations of discrepancies, failures
- 4832025-02-28
Defined areas of adequate size for operations
- 4832025-02-28
Validation lacking for sterile drug products
- recall — Class II2023-08-09
CGMP deviation: product released prior to supplier approval.
- recall — Class III2022-04-13
Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.
- 4832022-03-22
Investigations of discrepancies, failures
- 4832017-03-03
Following/documenting laboratory controls
Is this The Ritedose Corporation?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.